Follow
Richard Gelber
Richard Gelber
Professor, Harvard Medical School, Harvard TH Chan School of Public Health, Dana-Farber Cancer Institute, Frontier Science Foundation
Verified email at ds.dfci.harvard.edu
Title
Cited by
Cited by
Year
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart, M Procter, B Leyland-Jones, A Goldhirsch, M Untch, ...
New England Journal of Medicine 353 (16), 1659-1672, 2005
65362005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
61412005
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
EM Connor, RS Sperling, R Gelber, P Kiselev, G Scott, MJ O'sullivan, ...
New England Journal of Medicine 331 (18), 1173-1180, 1994
55381994
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn
Annals of oncology 22 (8), 1736-1747, 2011
47972011
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
42752013
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
22162015
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 379 (9814), 432-444, 2012
21892012
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21551998
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
19522009
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
I Smith, M Procter, RD Gelber, S Guillaume, A Feyereislova, M Dowsett, ...
The lancet 369 (9555), 29-36, 2007
19502007
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
SE Lipshultz, SD Colan, RD Gelber, AR Perez-Atayde, SE Sallan, ...
New England Journal of Medicine 324 (12), 808-815, 1991
16921991
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 16 (10), 1569-1583, 2005
15792005
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
J Baselga, I Bradbury, H Eidtmann, S Di Cosimo, E De Azambuja, C Aura, ...
The Lancet 379 (9816), 633-640, 2012
15672012
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer
G Von Minckwitz, M Procter, E De Azambuja, D Zardavas, M Benyunes, ...
New England Journal of Medicine 377 (2), 122-131, 2017
14432017
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 18 (7), 1133-1144, 2007
13152007
Analysis of survival by tumor response
JR Anderson, KC Cain, RD Gelber
J Clin Oncol 1 (11), 710-719, 1983
12831983
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
12702013
The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group
B Borgelt, R Gelber, S Kramer, LW Brady, CH Chang, LW Davis, ...
International Journal of Radiation Oncology* Biology* Physics 6 (1), 1-9, 1980
11801980
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ...
Journal of Clinical Oncology 14 (1), 18-24, 1996
11671996
Meeting highlights: international consensus panel on the treatment of primary breast cancer
A Goldhirsch, JH Glick, RD Gelber, AS Coates, HJ Senn
Journal of clinical Oncology 19 (18), 3817-3827, 2001
1162*2001
The system can't perform the operation now. Try again later.
Articles 1–20